| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.13B | $4.90B | $4.65B |
| YoY Revenue Growth % | +4.7% | +5.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.31B | $1.21B | $1.18B |
| Operating Margin % | 25.5% | 24.7% | 25.3% |
| Net Income (GAAP) | $596.0M | $501.1M | $463.0M |
| EBITDA (Normalized) | $1.45B | $1.34B | $1.35B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.88B | $1.88B | $1.66B |
| Capital Expenditures (CapEx) | $175.7M | $163.8M | $209.4M |
| Free Cash Flow (FCF) | $1.71B | $1.72B | $1.45B |
| FCF Margin % | 33.3% | 35.1% | 31.1% |
| Return on Invested Capital (ROIC %) | 9.3% | 8.5% | 27.6% |
| Cash & Short-Term Equivalents | $80.8M | $96.2M | — |
| Total Debt (Short + Long Term) | $7.38B | $7.51B | $1.31B |
| Total Stockholders' Equity | $3.78B | $3.80B | $2.68B |